Cover Image
市場調查報告書

全球次世代定序 (NGS) 市場預測

Global Next Generation Sequencing (NGS) Market Outlook: 2015-2020

出版商 Meticulous Market Research Pvt.Ltd. 商品編碼 348580
出版日期 內容資訊 英文 325 Pages
訂單完成後即時交付
價格
Back to Top
全球次世代定序 (NGS) 市場預測 Global Next Generation Sequencing (NGS) Market Outlook: 2015-2020
出版日期: 2015年08月03日 內容資訊: 英文 325 Pages
簡介

全球次世代定序 (NGS) 市場,預計從2015年到2020年以年複合成長率21.3%擴大,2020年達到85億9,950萬美元。該市場由於不斷的技術創新和手術開發,研究實驗室和學術機構的推廣,及降低成本等而促進擴大。

本報告提供全球次世代定序 (NGS) 市場相關調查、市場現狀與規模、市場佔有率、至2020年的預測、各手法/各產品與服務/各技術/各用途/各終端用戶/各地區的趨勢、競爭預測,及進入的主要企業簡介彙整。

第1章 次世代定序 (NGS) 市場簡介

第2章 摘要整理

第3章 市場概要

  • 促進要素
  • 阻礙要素
  • 機會
  • 市場佔有率分析
  • 市場趨勢

第4章 各手法市場

  • 基因學
  • 轉錄體學
  • 表觀基因

第5章 各產品與服務市場

  • NGS試劑及配件
  • 定序平台
  • 資料分析軟體及工具
  • 定序晶片
  • 服務
  • 其他

第6章 各技術市場

  • 平行信號測序
  • 焦磷酸定序
  • 合成的定序
  • SOLiD
  • Ion Torrent定序
  • tSMS
  • SMRT
  • 其他

第7章 各用途市場

  • 藥物研發
  • 遺傳基因篩檢
  • 診斷
  • 個人化醫療
  • 農業、動物研究
  • 其他

第8章 各終端用戶市場

  • 學術研究機關
  • 醫院、醫療機關
  • 生物醫藥品企業
  • 其他

第9章 各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭預測

  • 協定、聯盟、聯合、合資企業、擴充
  • 輔助金、融資
  • 授權
  • 合併、收購
  • 新產品上市
  • 專利
  • 推銷、行銷活動
  • 其他

第11章 企業簡介

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Azco Biotech, Inc.
  • Affymetrix, Inc
  • Agilent Technologies
  • BGI
  • Gatc Biotech Ag
  • Beckman Coulter Genomics, Inc.
  • Macrogen Corporation
  • Perkin Elmer, Inc.
  • Qiagen N.V
  • DNASTAR, Inc
  • Knome, Inc
  • Partek Incorporated
  • Genomatix Software Gmbh
  • Biomatters Ltd
  • GenoLogics Life Sciences Software, Inc.

圖表

目錄
Product Code: BT 1028

Over the traditional technologies such as Microarray and Sanger Sequencing, the term Next Generation Sequencing was figured to portray the evolutionary breakthrough in DNA sequencing technologies to increase accuracy and speed, and reduce cost of sequencing. With different approach to sequencing, next generation sequencing has triggered numerous ground-breaking discoveries and ignited a revolution in genomic science. The adoption of rapidly evolving next generation sequencing technology has increased with support of government bodies like National Human Genome Research Institute (NHGRI) and Biotechnological and Biological Sciences Research Council (BBSRC, U.K.) and promotion by various research laboratories and academicians across the globe.

The global Next Generation Sequencing market is expected to grow at a CAGR of 21.3% from 2015 to 2020 to reach $8,599.5 million by 2020. This market is mainly driven by continuous innovation and developments in the market, promotion of NGS by research laboratories and academics, reduced cost of sequencing with the use of NGS, and rising support from various government bodies to promote use of NGS in research and development. As a result, various companies in the pharmaceutical industry have recognized the potential benefits of next generation sequencing as a research and development tool. This is evident from the recent major events such as agreement between Roche and Foundation Medicine to acquire a majority interest in Foundation Medicine for approximately $780 million, and various other agreements and investments from the companies like Genentech, Pfizer, and 10x Genomics. Moreover, an increase rate of cancer diseases, drastically reduced mass scale genetic testing costs, growing economy, and increasing genetic research and development activities in countries like India, Singapore, and China provide significant opportunities for the players to invest in this market. However, decrease in capital expenditure from academic institutions, high reliability on grants and funds from government, accuracy and standardization concern in diagnostic testing, and legal and ethical issues related to next generation sequencing hinders the growth of this market.

The North America held the largest share in the global NGS market followed by Europe and Asia-Pacific. The Asia-Pacific region provides significant opportunities for the NGS with China and India being the most populous countries in this region contributing to the increased demand for advanced sequencing facilities like NGS. As, the NGS market in Asia-Pacific region is expected to grow at a highest CAGR during the forecast period; many players in this market are focusing on strengthening their position in this region.

The research report titled “Global Next Generation Sequencing Market Outlook: 2015-2020” provides in-depth analysis of NGS market in four major geographies with country level analysis and emphasizes on the current market trends, market size, market share, recent developments, and forecast till 2020. The study offers a comprehensive analysis of NGS market with respect to its products and services, technology, methods, end-users, and applications.

The key players in the global NGS market are Illumina, Inc., Pacific Biosciences, Roche Holding AG, Thermo Fisher Scientific, Knome, Inc., Perkin Elmer, Inc., Qiagen N.V., Beijing Genomics Institute, Agilent Technologies, Inc., Partek Incorporated, Macrogen, Inc., GenoLogics Life Sciences Software, Inc., and Biomatters, Ltd.

Key questions answered in the report-

  • Which are the high growth market segments in terms of NGS product and services, platforms, applications, end-users, methods, technology, regions, and countries?
  • What is the historical market for NGS across the globe?
  • What are the market forecasts and estimates from the period 2015-2020?
  • What are the major drivers, restrains, threats, and opportunities in the global NGS market?
  • What are the burning issues of the global NGS market?
  • Who are the major players in the global NGS market and what share of the market do they hold?
  • Who are the major players in various regions (North America, APAC, Europe) and what share of the market do they hold?
  • What are the competitive landscapes and who are the market leaders by sub-region in the global NGS market?
  • What are the recent developments in the global NGS market?
  • What are the different strategies adopted by the major players in the global NGS market?
  • What are the geographical trends and high growth regions?

Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publications, Government Publications, Company Press Releases, Company Annual Reports, Company Websites, Company Publications, SEC Filings, Meticulous Research Analysis.

Table of Contents

1. Introduction to Global NGS Market

  • 1.1. NGS Market Ecosystem
    • 1.1.1. NGS Methods
    • 1.1.2. NGS Products and Services
    • 1.1.3. NGS Technology
    • 1.1.4. NGS Application
    • 1.1.5. NGS End-Users
  • 1.2. Report Elucidation
  • 1.3. Market Buzz and Foreground
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Market Analytics

2. Executive Summary

3. Market Insights

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Market Share Analysis
  • 3.5. Market Trends

4. Global NGS- Market Crackdown ($ Value Analysis), By Methods

  • 4.1. Genomics
    • 4.1.1. Whole-Genome Sequencing
    • 4.1.2. Exome Sequencing
    • 4.1.3. De Novo Sequencing
    • 4.1.4. Targeted Sequencing
  • 4.2. Transcriptomics
    • 4.2.1. Total RNA and mRNA Sequencing
    • 4.2.2. Targeted RNA Sequencing
    • 4.2.3. Small RNA and Noncoding RNA Sequencing
  • 4.3. Epigenomics
    • 4.3.1. Methylation Sequencing
    • 4.3.2. ChIP Sequencing
    • 4.3.3. Ribosome Profiling

5. Global NGS – Market Crackdown ($ Value Analysis), By Products and Services

  • 5.1. NGS Reagents and accessories
    • 5.1.1. Library Preparation
    • 5.1.2. Template Preparation/Cluster generation
    • 5.1.3. Sequencing
    • 5.1.4. Others
  • 5.2. Sequencing platforms
    • 5.2.1. Illumina
    • 5.2.2. Thermo Fisher Scientific (Life Technologies)
    • 5.2.3. Roche
    • 5.2.4. Pacific Biosciences
  • 5.3. NGS Data analysis software and tools
  • 5.4. Sequencing chips
  • 5.5. NGS Services
  • 5.6. Others

6. Global NGS – Market Crackdown ($ Value Analysis), By Technology

  • 6.1. Massively Parallel Signature Sequencing (MPSS)
  • 6.2. Pyrosequencing
  • 6.3. Sequencing by Synthesis (SBS)
  • 6.4. Supported Oligonucleotide Ligation and Detection (SOLiD)
  • 6.5. Ion Torrent Sequencing
  • 6.6. True Single Molecule Sequencing (tSMS)
  • 6.7. Single Molecule Real Time (SMRT) Sequencing
  • 6.8. Other Sequencing Technologies

7. Global NGS – Market Crackdown ($ Value Analysis), By Application

  • 7.1. Drug Discovery
  • 7.2. Genetic Screening
  • 7.3. Diagnostics
  • 7.4. Personalized Medicine
  • 7.5. Agriculture And Animal Research
  • 7.6. Others

8. Global NGS – Market Crackdown ($ Value Analysis), By End-Users

  • 8.1. Academic and Research Organizations
  • 8.2. Hospitals & Healthcare Institutions
  • 8.3. Biopharma companies
  • 8.4. Others

9. NGS – Market Crackdown ($ Value Analysis), By Geography

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. U.K.
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. RoE
  • 9.3. Asia-Pacific
    • 9.3.1. Japan
    • 9.3.2. China
    • 9.3.3. India
    • 9.3.4. RoAPAC
  • 9.4. RoW
    • 9.4.1. Latin America
    • 9.4.2. Middle East & Africa

10. Global NGS Market- Competitive Outlook

  • 10.1. Agreements, Partnerships, Collaborations, Joint Ventures, and Expansions
  • 10.2. Grants & Funds
  • 10.3. Licensing
  • 10.4. Mergers and Acquisitions
  • 10.5. New Product Launches
  • 10.6. Patents
  • 10.7. Promotional & Marketing Activities
  • 10.8. Other Developments

11. Competitive Profiles – Major Players

  • 11.1. Illumina, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product & Services Portfolio
    • 11.1.4. Growth Strategies
  • 11.2. Thermo Fisher Scientific, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product & Services Portfolio
    • 11.2.4. Growth Strategies
  • 11.3. Roche Holding AG
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product & Services Portfolio
    • 11.3.4. Growth Strategies
  • 11.4. Pacific Biosciences of California, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product & Services Portfolio
    • 11.4.4. Growth Strategies
  • 11.5. Oxford Nanopore Technologies Ltd.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product & Services Portfolio
    • 11.5.4. Growth Strategies
  • 11.6. Azco Biotech, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product & Services Portfolio
    • 11.6.4. Growth Strategies
  • 11.7. Affymetrix, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product & Services Portfolio
    • 11.7.4. Growth Strategies
  • 11.8. Agilent Technologies
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product & Services Portfolio
    • 11.8.4. Growth Strategies
  • 11.9. BGI (Beijing Genomics Institute)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product & Services Portfolio
    • 11.9.4. Growth Strategies
  • 11.10. Gatc Biotech Ag
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product & Services Portfolio
    • 11.10.4. Growth Strategies
  • 11.11. Beckman Coulter Genomics, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product & Services Portfolio
    • 11.11.4. Growth Strategies
  • 11.12. Macrogen Corporation
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product & Services Portfolio
    • 11.12.4. Growth Strategies
  • 11.13. Perkin Elmer, Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product & Services Portfolio
    • 11.13.4. Growth Strategies
  • 11.14. Qiagen N.V
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product & Services Portfolio
    • 11.14.4. Growth Strategies
  • 11.15. DNASTAR, Inc
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product & Services Portfolio
    • 11.15.4. Growth Strategies
  • 11.16. Knome, Inc
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product & Services Portfolio
    • 11.16.4. Growth Strategies
  • 11.17. Partek Incorporated
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product & Services Portfolio
    • 11.17.4. Growth Strategies
  • 11.18. Genomatix Software Gmbh
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product & Services Portfolio
    • 11.18.4. Growth Strategies
  • 11.19. Biomatters Ltd
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product & Services Portfolio
    • 11.19.4. Growth Strategies
  • 11.20. GenoLogics Life Sciences Software, Inc.
    • 11.20.1. Company Overview
    • 11.20.2. Financial Performance
    • 11.20.3. Product & Services Portfolio
    • 11.20.4. Growth Strategies

List of Tables

  • Table 1: Global NGS Market Size By Method, Through 2020 ($Million)
  • Table 2: Global NGS Market Size By Country, Through 2020 ($Million)
  • Table 3: Global Genomics Market Size By Country, Through 2020 ($Million)
  • Table 4: Global Whole-Genome Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 5: Global Exome Sequencing Market Size By Product Type, Through 2020 ($Million)
  • Table 6: Global De Novo Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 7: Global Targeted Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 8: Global Transcriptomics Market Size By Country, Through 2020 ($Million)
  • Table 9: Global Total RNA and mRNA Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 10: Global Targeted RNA Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 11: Global Small RNA and Noncoding RNA Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 12: Global Epigenomics Market Size By Country, Through 2020 ($Million)
  • Table 13: Global Methylation Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 14: Global ChIP Sequencing Market Size By Country, Through 2020 ($Million)
  • Table 15: Global Ribosome Profiling Market Size By Country, Through 2020 ($Million)
  • Table 16: Global NGS Market: Size By Products and Services, Through 2020 ($Million)
  • Table 17: Global NGS Reagents and accessories Market: Size By Country, Through 2020 ($Million)
  • Table 18: Global Library Preparation Market: Size By Country, Through 2020 ($Million)
  • Table 19: Global Template Preparation/Cluster generation Market: Size By Country, Through 2020 ($Million)
  • Table 20: Global Sequencing Market: Size By Country, Through 2020 ($Million)
  • Table 21: Global Others Market: Size By Country, Through 2020 ($Million)
  • Table 22: Global Sequencing platforms Market Size By Country, Through 2020 ($Million)
  • Table 23: Global Illumina Market: Size By Country, Through 2020 ($Million)
  • Table 24: Global Thermo Fisher Scientific (Life Technologies) Market: Size By Country, Through 2020 ($Million)
  • Table 25: Global Roche Market Size By Country, Through 2020 ($Million)
  • Table 26: Global Pacific Biosciences Market: Size By Country, Through 2020 ($Million)
  • Table 27: Global NGS Data analysis software and tools Market: Size By Country, Through 2020 ($Million)
  • Table 28: Global Sequencing chips Market: Size By Country, Through 2020 ($Million)
  • Table 29: Global NGS Services Market Size By Country, Through 2020 ($Million)
  • Table 30: Global: Others Market: Size By Country, Through 2020 ($Million)
  • Table 31: Global NGS Market: Size By Technology, Through 2020 ($Million)
  • Table 32: Global Massively Parallel Signature Sequencing (MPSS) Market Size By Country, Through 2020 ($Million)
  • Table 33: Global: Pyrosequencing Market: Size By Country, Through 2020 ($Million)
  • Table 34: Global Sequencing by Synthesis (SBS) Market: Size By Country, Through 2020 ($Million)
  • Table 35: Global Supported Oligonucleotide Ligation and Detection (SOLiD) Market Size By Country, Through 2020 ($Million)
  • Table 36: Global Ion Torrent Sequencing Market: Size By Country, Through 2020 ($Million)
  • Table 37: Global True Single Molecule Sequencing (tSMS) Market: Size By Country, Through 2020 ($Million)
  • Table 38: Global Single Molecule Real Time (SMRT) Sequencing Market: Size By Country, Through 2020 ($Million)
  • Table 39: Global Other Sequencing Technologies Market Size By Country, Through 2020 ($Million)
  • Table 40: Global: NGS Market: Size By Application, Through 2020 ($Million)
  • Table 41: Global Drug Discovery Market Size By Country, Through 2020 ($Million)
  • Table 42: Global: Genetic Screening Market: Size By Country, Through 2020 ($Million)
  • Table 43: Global Diagnostics Market: Size By Country, Through 2020 ($Million)
  • Table 44: Global Personalized Medicine Market Size By Country, Through 2020 ($Million)
  • Table 45: Global Agriculture And Animal Research Market: Size By Country, Through 2020 ($Million)
  • Table 46: Global Others Market: Size By Country, Through 2020 ($Million)
  • Table 47: Global NGS Market: Size By End-Users, Through 2020 ($Million)
  • Table 48: Global: Academic and Research Organizations Market: Size By Country, Through 2020 ($Million)
  • Table 49: Global Hospitals & Healthcare Institutions Market: Size By Country, Through 2020 ($Million)
  • Table 50: Global Biopharma companies Market Size By Country, Through 2020 ($Million)
  • Table 51: Global OthersMarket: Size By Country, Through 2020 ($Million)
  • Table 52: North America:NGS Market Size By Country, Through 2020 ($Million)
  • Table 53: North America:NGS Market Size By Method, Through 2020 ($Million)
  • Table 54: North America:NGS Market Size By Products and Services, Through 2020 ($Million)
  • Table 55: North America:NGS Market Size By Technology, Through 2020 ($Million)
  • Table 56: North America:NGS Market Size By Application, Through 2020 ($Million)
  • Table 57: North America:NGS Market Size By End-Users, Through 2020 ($Million)
  • Table 58: Europe:NGS Market Size By Country, Through 2020 ($Million)
  • Table 59: Europe:NGS Market Size By Method, Through 2020 ($Million)
  • Table 60: Europe:NGS Market Size By Products and Services, Through 2020 ($Million)
  • Table 61: Europe:NGS Market Size By Technology, Through 2020 ($Million)
  • Table 62: Europe:NGS Market Size By Application, Through 2020 ($Million)
  • Table 63: Europe:NGS Market Size By End-Users, Through 2020 ($Million)
  • Table 64: Asia-Pacific:NGS Market Size By Country, Through 2020 ($Million)
  • Table 65: Asia-Pacific:NGS Market Size By Method, Through 2020 ($Million)
  • Table 66: Asia-Pacific:NGS Market Size By Products and Services, Through 2020 ($Million)
  • Table 67: Asia-Pacific:NGS Market Size By Technology, Through 2020 ($Million)
  • Table 68: Asia-Pacific:NGS Market Size By Application, Through 2020 ($Million)
  • Table 69: Asia-Pacific:NGS Market Size By End-Users, Through 2020 ($Million)
  • Table 70: Rest of the World:NGS Market Size By Country, Through 2020 ($Million)
  • Table 71: Rest of the World:NGS Market Size By Method, Through 2020 ($Million)
  • Table 72: Rest of the World:NGS Market Size By Products and Services, Through 2020 ($Million)
  • Table 73: Rest of the World:NGS Market Size By Technology, Through 2020 ($Million)
  • Table 74: Rest of the World:NGS Market Size By Application, Through 2020 ($Million)
  • Table 75: Rest of the World:NGS Market Size By End-Users, Through 2020 ($Million)
  • Table 76: NGS Market- New Product Launches
  • Table 77: NGS Market- Mergers and Acquisitions
  • Table 78: NGS Market- Agreements, Collaboration, and Partnerships
  • Table 79: NGS Market- Other Developments
Back to Top